Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Publication year range
1.
Rev. nefrol. diál. traspl ; Rev. nefrol. diál. traspl. (En línea);39(2): 115-119, jun. 2019. tabl.
Article in Spanish | LILACS, BINACIS | ID: biblio-1352751

ABSTRACT

El quiloperitoneo es una condición infrecuente que se asocia a diálisis peritoneal; en la mayoría de los casos se puede confundir con peritonitis bacteriana, aunque puede ser la consecuencia de esta infección. Se reporta el desarrollo espontáneo de quiloperitoneo en un paciente de 54 años con enfermedad renal crónica secundaria a nefropatía diabética, en diálisis peritoneal manual desde hacía 5 años. El tratamiento consistió en suspensión temporal de la diálisis peritoneal, reposo intestinal, suministro de una dieta con alto contenido de ácidos grasos de cadena media e infusión de octreotide, con lo cual a los 10 días el paciente mostró mejoría, y se reinició la diálisis peritoneal. Una búsqueda sistemática de la literatura encontró 16 casos publicados (11 mujeres), con edades desde neonato hasta 88 años.


Chyloperitoneum is a rare condition associated with peritoneal dialysis. In most cases it is misdiagnosed as bacterial peritonitis, but it can also be a consequence of this infection. We present the spontaneous development of chyloperitoneum in a 54 year old patient with chronic kidney disease secondary to diabetic nephropathy, in manual peritoneal dialysis for 5 years. The treatment consisted of temporary suspension of peritoneal dialysis, bowel rest, supply of a diet with a high content of medium chain fatty acids and infusion of octreotide. After 10 days the patient showed improvement, and peritoneal dialysis was restarted. A systematic search of the literature found 16 published cases (11 women), ranging in age from newborn to 88 years.


Subject(s)
Humans , Male , Middle Aged , Chylous Ascites/diagnosis , Chylous Ascites/diet therapy , Chylous Ascites/drug therapy , Peritoneal Dialysis/adverse effects , Renal Dialysis , Rare Diseases
2.
Rev. AMRIGS ; 51(1): 62-66, jan.-mar. 2007. tab
Article in Portuguese | LILACS | ID: lil-685175

ABSTRACT

Efusão quilosa pleural ou quilotórax significa acúmulo quiloso no espaço pleural, geralmente como ruptura secundária dos ductos linfáticos torácicos, que pode ser promovida por vários estímulos, desde trauma, doenças malignas até causas idiopáticas. É definido como uma efusão de linfa na cavidade pleural, podendo ter origem no tórax ou na cavidade abdominal, ou em ambos. É de aspecto leitoso, inodoro, branco, de pH alcalino com gravidade específica acima de 1012, bacteriostático, não irritativo à pleura. É opalescente, formado quando triglicérides de cadeia longa da dieta são transformados em quilomícrons de baixa densidade lipoprotéica secretados no intestino. O quilo é transportado através do ducto torácico e drenado na veia subclávia esquerda. O diagnóstico é baseado em análise clínica da efusão pleural contendo quilomícrons e níveis de triglicérides maior que 110 mg/dL como indicativo praticamente certo de efusão pleural quilosa. A conduta depende da causa e das circunstâncias individuais. Um relato de quilotórax bilateral e quiloascite espontâneos é apresentado com ótima evolução através de tratamento conservador com a utilização de dieta enteral oligomérica, rica em aminoácidos, com glutamina e mínima oferta de triglicérides de cadeia média e octeotride


Chylous pleural effusion or chylothorax means chyle accumulation in the pleural space generally as a secondary disruption of thoracic lymphatics, that can be promoted by various stimulants, since trauma, malignancies, to idiopathic causes. Is defined as an effusion of limphin pleural cavity. Chyle may have its origin in the thorax or in the abdomen, or both. Is a milky, white, alkaline pH with a specific gravity above 1012, bacteriostatic and nonirritating to thepleural space, opalescent fluid formed when long-chain triglycerides in the diet are transformed into chylomicrons and very-low-density lipoproteins and secreted into intestinal lacteals. The chyle is transported through the thoracic duct and drained into the left subclavian vein. Diagnosis is based on a chemical analysis of the pleural effusion presenting chylomicrons, pleural triglyceride with levels greater than 110 mg/dL being nearly always indicative of a chylous pleural effusion. Management depends on the underlying cause and the individual circumstances. A case report of spontaneous chylothorax and chyloascitis is presented successfullytreated by conservative means, using oligomeric enteral feeding, rich in amino acids with minimum quantity of medium-chain-triglycerides, glutamine, and octeotride


Subject(s)
Humans , Male , Adult , Chylous Ascites/surgery , Chylous Ascites/diagnosis , Chylous Ascites/diet therapy , Chylothorax/surgery , Chylothorax/diagnosis , Chylothorax/diet therapy , Chylous Ascites/etiology , Chylothorax/etiology
3.
Rev. chil. pediatr ; 60(4): 220-1, jul.-ago. 1989. ilus
Article in Spanish | LILACS | ID: lil-75653

ABSTRACT

Se presenta el caso clínico de un recién nacido que presenta ascitis quilosa de causa no identificada. Se manejó con régimen a base de aminoácidos y triglicéridos de cadena media e hidratos de carbono, evolucionando satisfactoriamente. Un año después su peso, talla y desarrollo psicomotor eran normales y no había evidencia de ascitis


Subject(s)
Infant, Newborn , Humans , Female , Chylous Ascites/diet therapy , Chylous Ascites/diagnosis
4.
Rev Chil Pediatr ; 60(4): 220-1, 1989.
Article in Spanish | MEDLINE | ID: mdl-2485513

ABSTRACT

Chylous ascites was recognized by abdominal ultrasonography in a 37 week gestational age newborn girl presenting with early transient respiratory distress syndrome, hypoglycemia and progressive abdominal distension. Diagnosis was confirmed by abdominal puncture. Treatment was focussed on dietary management which included oral amino acids, vitamins, medium chain triglycerides, maltose-dextrin; commercial rice starch and cane sugar and was followed by complete recovery at age two months.


Subject(s)
Chylous Ascites/diet therapy , Infant, Premature, Diseases/diet therapy , Chylous Ascites/diagnosis , Female , Humans , Infant, Newborn , Infant, Premature, Diseases/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL